Clinical trial
Platform for the Prospective Mother-child Study of the Determinants of Autism Spectrum Disorder and Neurodevelopmental Disorders Neurodevelopmental Disorders
NCT05681923 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Platform for the Prospective Mother-child Study of the Determinants of Autism Spectrum Disorder and Neurodevelopmental Disorders Neurodevelopmental Disorders
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 19, 2023
- Completion date
- March 31, 2034
- Enrollment
- 7,320 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.